1-deoxynojirimycin has been researched along with 1,5-anhydroglucitol in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aoki, K; Nakajima, S; Nezu, U; Shinoda, K; Terauchi, Y | 1 |
| Hamaguchi, T; Katsuno, T; Konishi, K; Kusunoki, Y; Miuchi, M; Miyagawa, J; Murai, K; Nagai, E; Namba, M; Ochi, F; Tokuda, M | 1 |
| Kishimoto, M; Noda, M | 1 |
2 trial(s) available for 1-deoxynojirimycin and 1,5-anhydroglucitol
| Article | Year |
|---|---|
Comparison of pre- vs. postmeal administration of miglitol for 3 months in type 2 diabetic patients.
Topics: 1-Deoxynojirimycin; Analysis of Variance; Biomarkers; Deoxyglucose; Diabetes Mellitus, Type 2; Drug Administration Schedule; Glycated Hemoglobin; Glycoside Hydrolase Inhibitors; Humans; Hypoglycemic Agents; Insulin; Postprandial Period | 2008 |
Effects of miglitol in combination with intensive insulin therapy on blood glucose control with special reference to incretin responses in type 1 diabetes mellitus.
Topics: 1-Deoxynojirimycin; Adult; Aged; Deoxyglucose; Diabetes Mellitus, Type 1; Drug Therapy, Combination; Enzyme Inhibitors; Gastric Inhibitory Polypeptide; Glucagon-Like Peptide 1; Glycated Hemoglobin; Glycated Serum Albumin; Glycation End Products, Advanced; Glycoside Hydrolase Inhibitors; Humans; Hyperglycemia; Hypoglycemia; Hypoglycemic Agents; Incretins; Insulin; Male; Middle Aged; Serum Albumin; Weight Loss; Young Adult | 2011 |
1 other study(ies) available for 1-deoxynojirimycin and 1,5-anhydroglucitol
| Article | Year |
|---|---|
A pilot study of the efficacy of miglitol and sitagliptin for type 2 diabetes with a continuous glucose monitoring system and incretin-related markers.
Topics: 1-Deoxynojirimycin; Aged; Biomarkers; Blood Glucose; Case-Control Studies; Deoxyglucose; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Female; Gastric Inhibitory Polypeptide; Glucagon; Glucagon-Like Peptide 1; Glycoside Hydrolase Inhibitors; Humans; Hyperglycemia; Hypoglycemic Agents; Incretins; Insulin; Male; Middle Aged; Monitoring, Physiologic; Pilot Projects; Postprandial Period; Pyrazines; Sitagliptin Phosphate; Triazoles | 2011 |